NCT02062346View on ClinicalTrials.gov

Endothelin Antagonism in ANCA Vasculitis

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Vasculitis
Interventions
DRUG

BQ123

Intravenous infusion of BQ123 ( selective ETA antagonist )

DRUG

BQ123/788

or BQ123/788 (mixed ETA/B antagonists)

DRUG

Placebo

Intravenous infusion of saline

Trial Locations (2)

EH16 4TJ

University of Edinburgh, Edinburgh

Unknown

University of Edinburgh, Edinburgh

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

University of Edinburgh

OTHER

NCT02062346 - Endothelin Antagonism in ANCA Vasculitis | Biotech Hunter | Biotech Hunter